New diabetes pill shows Real-World promise in spanish study
NCT ID NCT05443334
First seen Sep 30, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study looked at how well the diabetes pill Rybelsus® (oral semaglutide) controls blood sugar and weight in adults with type 2 diabetes in Spain. About 465 people took the medicine as prescribed by their doctor and filled out questionnaires about their treatment. The goal was to see real-world results, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Master Centre for Spain
Barcelona, 08025, Spain
-
Master Centre for Spain
Madrid, 28033, Spain
Conditions
Explore the condition pages connected to this study.